stockrow
Monday 9 November 2026
Export ETRA’s income statement to Excel — free account
Electra Therapeutics Inc.
ETRA
8.52
0.72
+9.23%
Follow ETRA
Alert me
Electra Therapeutics Inc. (ETRA) Return on invested capital
Return on invested capital, annual
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| DMAC DiaMedica Therapeutics, Inc. compare | 0.00% |
| CBIO Crescent Biopharma, Inc. compare | 0.00% |
| INDP Indaptus Therapeutics, Inc. compare | 0.00% |
| MNPR Monopar Therapeutics Inc. compare | 0.00% |
| RGNX REGENXBIO Inc. compare | 0.00% |
| MDXG MiMedx Group, Inc compare | −17.4% |
| CTMX CytomX Therapeutics, Inc. compare | −20.8% |
| STTK Shattuck Labs, Inc. compare | −1,230.7% |
| ETRA Electra Therapeutics Inc. | — |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)